Navid Hafez
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Pathology and Forensic Medicine top 10%
- Cancer Research
- Co-authors
- Alexander I. SpiraRona YaegerTanios Bekaii‐SaabHirak Der‐TorossianKaren VelasteguiMinal BarveJoshua K. SabariDaniel P. Petrylak
- Topics
- Cancer Immunotherapy and Biomarkers (8 papers)PARP inhibition in cancer therapy (6 papers)Colorectal Cancer Treatments and Studies (5 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Navid Hafez
31 papers receiving 719 citations
Hit Papers
Peers
Comparison fields: 5 of 54
- Oncology 530
- Molecular Biology 229
- Pulmonary and Respiratory Medicine 126
- Pathology and Forensic Medicine 119
- Cancer Research 117
Countries citing papers authored by Navid Hafez
This map shows the geographic impact of Navid Hafez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navid Hafez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navid Hafez more than expected).
Fields of papers citing papers by Navid Hafez
This network shows the impact of papers produced by Navid Hafez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navid Hafez. The network helps show where Navid Hafez may publish in the future.
Co-authorship network of co-authors of Navid Hafez
This figure shows the co-authorship network connecting the top 25 collaborators of Navid Hafez. A scholar is included among the top collaborators of Navid Hafez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navid Hafez. Navid Hafez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | Adagrasib in Advanced Solid Tumors Harboring aKRASG12CMutationbreakdown → | 139 |
| 8 | 6 | |
| 9 | 31 | |
| 10 | 45 | |
| 11 | 56 | |
| 12 | 3 | |
| 13 | 83 | |
| 14 | 9 | |
| 15 | 7 | |
| 16 | 17 | |
| 17 | 141 | |
| 18 | 14 | |
| 19 | 1 | |
| 20 | 15 |
About Navid Hafez
Navid Hafez is a scholar working on Oncology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 723 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), PARP inhibition in cancer therapy (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Oncology (530 citations), Cancer Research (117 citations) and Pathology and Forensic Medicine (119 citations). Navid Hafez has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Alexander I. Spira, Rona Yaeger, Tanios Bekaii‐Saab, Hirak Der‐Torossian, Karen Velastegui, Minal Barve, Joshua K. Sabari, Daniel P. Petrylak, Xiaohong Yan and Meredith Pelster. Their work appears in journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.